再次经尿道电切术在非肌层浸润性膀胱癌临床治疗中的价值研究

The clinical value of transurethral resection(ReTUR) in patients with bladder cancer without muscle invasion

目的观察分析对非肌层浸润性膀胱癌患者采用再次经尿道电切术（Re TUR）进行治疗的临床应用价值。方法选取2010年2月-2012年2月收治的非肌层浸润性膀胱癌患者60例作为临床研究对象,使用随机数字列表法将其分成研究组和对照组,各30例。对照组患者采用单次经尿道电切术（TUR）进行治疗,研究组患者在TUR术后4-6周时采用Re TUR进行治疗,观察比较两组患者的治疗效果。结果所有患者均顺利完成手术,均未产生不良并发症。研究组患者的术后复发率、进展率均明显低于对照组,差异均有统计学意义（P〈0.05）;研究组患者的复发时间明显长于对照组,差异有统计学意义（P〈0.05）。结论 Re TUR在非肌层浸润型膀胱癌患者中具有良好的临床应用价值,值得在临床上推广。

Objective To observe and analyze the clinical value of the treatment of patients with bladder cancer with non muscle invasive bladder cancer by transurethral resection （ReTUR） .Methods A total 60 cases of patients with non muscle invasive bladder cancerwho treated in hospitalwere selected as clinical study objects from February 2012 to February 2014, and randomly divided into study group and control group, 30 cases in each. The control group was treated by single transurethral resection （TUR）, and the patients in the study group were treated ReTURweeks after 4 - 6weeksTUR.Compared the treatment effect of two groups of patients. Results 60 patients were successfully completed the surgery, no adverse complications. The postoperative recurrence rate and the progress rate of the study group were significantly lower than that of the control group, and the differences were statistically significant （P 〈 0.05 ）. The recurrence time of the study group was significantly higher than that of the control group , the difference was statistically significant （P 〈 0.05 ）. Conclusion ReTUR has good clinical application value in patients with non muscle invasive bladder cancer, and it is worthy of further popularization in clinic.